Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lily Cannon"'
Autor:
Dimitrios Farmakis, Michael Angastiniotis, Maria-Melina El Ghoul, Lily Cannon, Androulla Eleftheriou
Publikováno v:
Hemoglobin. 46(4)
Disease registries can be extremely powerful evidence generating tools while providing a central meeting point for all implicated stakeholders, facilitating their networking and interaction. Registries can play a major role in addressing the challeng
Autor:
Michael Angastiniotis, Androulla Eleftheriou, Eleni Antoniou, Dimitris Loukopoulos, Angelo Loris Brunetta, Eva Maria Knoll, Lily Cannon, Anton Skafi, George Constantinou
Publikováno v:
Thalassemia Reports; Volume 11; Issue 1; Pages: 9803
Hemoglobin disorders (thalassemia and sickle cell disease) are a group of hereditary anemias that today occur across the world. The recent population movement has led to a steady increase of carriers and patients in all countries of the European Unio
Autor:
Androulla Eleftheriou, Dimitrios Farmakis, Lily Cannon, Michael Angastiniotis, Anastasios Giakoumis
Publikováno v:
European Journal of Haematology
Objectives Many patients with haemoglobinopathies, including thalassaemia and sickle cell disease, are at increased risk of developing severe complications from the coronavirus disease 2019 (COVID‐19). Although epidemiologic evidence concerning the
Publikováno v:
Thalassemia Reports; Volume 10; Issue 1; Pages: 9138
Patients with haemoglobin disorders, particularly β-thalassaemia or sickle cell disease (SCD) or combined forms, on account of their underlying disease pathology and associated (iron load mainly in the case of thalassaemia) co-morbidities are define